# Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy

> **NCT07574385** · PHASE2 · RECRUITING · sponsor: **Rebel Medicine Inc** · enrollment: 60 (estimated)

## Conditions studied

- Hallux Valgus
- Bunionectomy

## Interventions

- **DRUG:** ALX006 (bupivacaine extended-release injection)
- **DRUG:** Bupivacaine Hcl 0.25% Inj
- **PROCEDURE:** Sciatic Nerve Block

## Key facts

- **NCT ID:** NCT07574385
- **Lead sponsor:** Rebel Medicine Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07574385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07574385, "Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07574385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*